Although initiation of HAART managed to suppress viral load and boost the CD4 count, it did not restore the influenza-specific immunity even after 12months on HAART, suggesting that this intervention alone may not rapidly reduce the risk of influenza-related complications. This evidence concerns the gene CD4 and influenza.